Faculty Information - HORIUCHI Kiyomi

■ Published papers

1.	Case report	Advanced disease and biochemical phenotype shift in multiple endocrine neoplasia type 2A-related pheochromocytoma 2026/03/12
2.	Case report	Discordance of intrinsic subtype between primary tumor and lymph node metastasis in breast cancer patients 2026/03
3.	Case report	Reliability of CT attenuation value for adrenal masses 2026/02/20
4.	Case report	Fascin expression is associated with aggressive clinicopathological features in parathyroid tumors 2026/02/11
5.	Original article	Impact of extent thyroidectomy and radioactive iodine ablation for disease free survival in the intermediate-risk patients with lateral neck lymph node metastasis: a retrospective and tentative real-world approach 2025/07/03
6.	Original article	Predicting Tumor Volume in Primary Hyperparathyroidism From Preoperative Clinical Data 2025/01/21
7.	Original article	Outcomes of Patients with an Intermediate-Risk Group According to the Japanese Risk Classification of Papillary Thyroid Carcinoma 2023/06
8.	Original article	Predictive value of metastatic lateral lymph node ratio for recurrence in pathologically lateral lymph node-positive papillary thyroid cancer patients with palpable lymph nodes 2022/07
9.	Original article	Fatigue and quality of life among thyroid cancer survivors without persistent or recurrent disease 2022/03/16
10.	Case report	A case of tertiary hyperparathyroidism due to hypophosphatemic rickets 2022/02/25
11.	Case report	Papillary thyroid microcarcinoma with multiple pulmonary metastases following lung cancer surgery: a case report 2022
12.	Review article	Radioactive iodine treatment of papillary thyroid carcinoma in Japan 2020/05
13.	Original article	Low‑dose radioiodine therapy for patients with intermediate‑ to high‑risk differentiated thyroid cancer 2019/12/13
14.	Review article	International comparison of papillary thyroid carcinoma treatment according to clinical guidelines -　Postoperative adjuvant therapy - 2019
15.	Original article	Impact of Tailored parathyroidectomy for treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1 2018
16.	Original article	Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up 2018
17.	Case report	Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case. 2017/12
18.	Original article	safety and tolerability of vandetanib in japanese patients with medullary thyroid cancer: a phase I/II open-label study 2017/02
19.	Original article	An analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution 2013
20.	Original article	clinical features of insulinoma in patients with multiple endocrine neoplasia type1: analysis of the database pf the MEN consortium pf Japan 2012/06
21.	Original article	delay in the diagnosis of multiple endocrine neoplasia type 1: typical symptms are frequently overlooked 2012/02
22.	Original article	multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database 2012
23.	Original article	Usefulness and indication of 99m Tc-methoxyisobutylisonitrile(MIBI) for preoperative localization in patients with primary hyperparathyroidism 1997
Display 5 items
Display all(23)

■ Academic conference presentation

1.	A case of decreased urinary metanephrines resulting from reduced serum catecholamines in a patient with multiple endocrine neoplasia type 2B treated with selpercatinib （Poster notice，General） 2025/04/03
2.	Practical guideline and changes for diagnosis and treatment of adrenal incidentaloma （Speech，Panelist at Symposium/Workshop (Appointed)） 2025/04/03
3.	HOW WILL NEWLY DEVELOPING TARGETED THERAPIES CHANGE THE SEQUENCE OF THYROID CANCER MANAGEMENT? AN ENDOCRINE SURGEON’S PERSPECTIVE （Speech，Panelist at Symposium/Workshop (Appointed)） 2024/08/29
4.	Reevaluating surgical indications for asymptomatic primary hyperparathyroidism: hypercalciuria is not a urinary stone risk （Poster notice，General） 2024/08/27
5.	The frequency of postoperative hypoglycemia after pheochromocytoma surgery is decreasing （Speech，General） 2024/08/27
6.	The postoperative clinical course of pheochromocytoma in patients with multiple endocrine neoplasia type2 (MEN2) （Poster notice，General） 2024/08/27
7.	Surgery for primary hyperparathyroidism in MEN1 （Speech，General） 2023/03/17
8.	Impact of urinary calcium excretion on urinary stones primary hyperparathyroidism （Poster notice，General） 2023/03/16
9.	Predicting tumor volume in primary hyperparathyroidism from preoperative clinical data （Poster notice，General） 2023/03/16
10.	Quality of life in patients with primary hyperparathyroidism without surgery （Speech，General） 2023/03/16
11.	Lateral neck dissection （Speech，Panelist at Symposium/Workshop (Appointed)） 2020/03/07
12.	Treatment outcomes of papillary thyroid carcinoma following the Japanese guidelines for the management of thyroid tumors 2020 （Poster notice，General） 2019/10/31
13.	Mulifocal papillary thyroid carcinoma : is completion thyroidectomy necessary to improve the prognosis? （Poster notice，General） 2019/08/11
14.	Report of MEN1 Registry of Japan. 2018/03/08
15.	Prognosis and prognostic factors for cancer mortality in patients with lymph node metastases from papillary thyroid carcinoma as a first-time recurrence （Poster notice，General） 2017/10/19
16.	Prediction of malignancy in thyroid nodules with macrocalcification by ultrasonography （Poster notice，General） 2017/09/09
17.	Impact of risk classification of papillary thyroid carcinoma based on the Japanese clinical guideline and prognostic factors in gray zone （Poster notice，General） 2017/08/14
18.	CLINICOPATHOLOGICAL CHARACTERISTICS OF FALSE NEGATIVE CASES IN FDG-PET/CT SCAN PERFORMED AS PREOPERATIVE AXILLARY ASSESSMENT FOR INVASIVE BREAST CANCER （Poster notice） 2017/08
19.	What treatment should be selected to obtain longer time to treatment failure (TTF) in HER2 negative metastatic breast cancer: the evaluation of the impact of agents on prognosis （Poster notice） 2017/08
20.	The current treatment of primary hyperparathyroidism in MEN1 in Japan: the analysis of data from MEN consortium of Japan. （Speech，Panelist at Symposium/Workshop (Appointed)） 2016/10/24
21.	Use of Fulvestrant for inoperable/recurrent breast cancer patients in our hospital （Speech，Panelist at Symposium/Workshop (Other)） 2016/10/22
22.	The current treatment for primary hyperparathyroidism in MEN1 in Japan: the analysis of data from MEN Consortium of Japan （Speech，General） 2016/10/01
23.	Parathyroid carcinoma in MEN1:report of a case （Poster notice，General） 2016/09/30
24.	Long-term prognosis of advanced papillary thyroid carcinoma with extra-thyroidal extension: Role of "shaving-off" resection （Speech，General） 2016/04/08
25.	Correlation of immediate reconstruction with clinical outcome to locally advanced breast cancer （Poster notice，General） 2015/12/20
26.	Predicting no metastases to axillary lymph nodes beyond positive sentinel nodes in patients with breast cancer: a simple rule （Poster notice，General） 2015/12/20
27.	Factors associated with long-term biochemical cure after surgical treatment of hereditary medullary thyroid carcinoma(HMTC) （Poster notice，General） 2015/10/20
28.	Clinical outocomes of individualized approarch of parathyroidectomy to patients with primary hyperparathyroidism(PHPT) in multiple endocrine neoplasia type 1(MEN1):the experienced at a single institution （Poster notice，General） 2014/09/26
29.	Cinacalcet has a limited effect in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: a case report （Poster notice，General） 2013/09/21
Display 5 items
Display all(29)

■ Qualifications & licenses

1.

2021/05/01

Board-certified Senior Doctor Member of the Japanese Society for Hereditary Tumors

■ Research areas

General surgery and pediatric surgery

■ Awards & honors

1.

2007/08

International Association of Endocrine Surgery IAES　poster　prize

■ Education

1.

Faculty of Medicine, Tokyo Women's Medical University, Graduated

■ Academic & professional experience

1.	2022/02	Tokyo　Women's　Medical University Endocrine　Surgery Associate Professor
2.	2000/04～2007/03	Research Assistant